RegentAtlantic Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,986
| Closed | -$217K | – | 689 |
|
|
2022
Q1 | $217K | Buy |
+3,986
| New | +$217K | 0.01% | 643 |
|
|
2021
Q4 | – | Sell |
-4,227
| Closed | -$202K | – | 693 |
|
|
2021
Q3 | $202K | Buy |
+4,227
| New | +$202K | 0.01% | 636 |
|
|
2020
Q4 | – | Sell |
-13,377
| Closed | -$629K | – | 512 |
|
|
2020
Q3 | $629K | Buy |
13,377
+9,400
| +236% | +$442K | 0.03% | 292 |
|
|
2020
Q2 | $203K | Buy |
+3,977
| New | +$203K | 0.01% | 453 |
|
|
2017
Q4 | – | Sell |
-5,167
| Closed | -$262K | – | 424 |
|
|
2017
Q3 | $262K | Sell |
5,167
-7
| -0.1% | -$355 | 0.02% | 353 |
|
|
2017
Q2 | $279K | Buy |
5,174
+80
| +2% | +$4.31K | 0.03% | 341 |
|
|
2017
Q1 | $268K | Buy |
+5,094
| New | +$268K | 0.02% | 348 |
|
|
2016
Q4 | – | Sell |
-4,110
| Closed | -$222K | – | 390 |
|
|
2016
Q3 | $222K | Sell |
4,110
-858
| -17% | -$46.3K | 0.02% | 358 |
|
|
2016
Q2 | $269K | Sell |
4,968
-403
| -8% | -$21.8K | 0.03% | 336 |
|
|
2016
Q1 | $272K | Buy |
5,371
+691
| +15% | +$35K | 0.03% | 326 |
|
|
2015
Q4 | $236K | Buy |
+4,680
| New | +$236K | 0.03% | 339 |
|
|
2015
Q1 | – | Sell |
-2,478
| Closed | -$132K | – | 569 |
|
|
2014
Q4 | $132K | Buy |
+2,478
| New | +$132K | 0.01% | 419 |
|